Kienbaum P, Prante C, Lehmann N, Sander A, Jalowy A, Peters J
Klinik für Anäesthesiologie und Intensivmedizin, Universitätsklinikum Essen, Essen, Germany.
Anaesthesia. 2008 Feb;63(2):121-8. doi: 10.1111/j.1365-2044.2007.05286.x.
Patients with septic shock are haemodynamically unstable and suffer from vasodilation. Studying the human forearm vascular bed in patients with septic shock, we tested the hypothesis that the responses to regionally infused endothelium-(in)dependent vasodilators and vasoconstrictors are uniformly impaired. Forearm blood flow (FBF, venous occlusion plethysmography) and brachial arterial pressure were determined to calculate forearm vascular resistance (FVR) in eight consecutive sedated, mechanically ventilated patients with septic shock (APACHE II Score range 21-34, SOFA Score 11-16) and 11 healthy volunteers. Despite increased baseline FBF in patients with septic shock (6.1 (SD 1.5) ml x min(-1) x (100 ml of tissue)(-1) compared to 4.7 (1.4) in volunteers) the significant decreases in FVR seen in response to exogenous nitric oxide (nitroprusside) and acetylcholine did not differ between groups. However, compared to volunteers, mitigation of endogenous nitric oxide production by a low dose of N(G)-methyl-L-arginine acetate (L-NMMA) caused a significant increase (+6.7 mmHg x min x ml(-1)) in septic patients. Regional vasoconstriction in response to phenylephrine (FVR: +9.9 vs +30.7 mmHg x min x ml(-1) in controls) and angiotensin II (FVR: +9.0 vs +67.4 mmHg x min x ml(-1)) was markedly impaired. In contrast, vasopressin, in dosages evoking no vasoconstriction in volunteers, induced a significant increase in FVR in septic patients (+10.0 mmHg x min x ml(-1)). In the forearm of patients with septic shock, vasoconstriction by alpha1- and angiotensin II receptor agonists is selectively impaired, whereas the vasoconstrictor response to vasopressin is exaggerated. These findings exclude a generalised impairment of vasomotor activity in patients with septic shock and provide a rationale for vasopressin administration.
感染性休克患者血流动力学不稳定,存在血管扩张。在感染性休克患者的人体前臂血管床研究中,我们检验了以下假设:对局部输注的内皮依赖性血管舒张剂和血管收缩剂的反应均受到损害。连续纳入8例镇静、机械通气的感染性休克患者(急性生理与慢性健康状况评分系统II评分范围为21 - 34,序贯器官衰竭评估评分11 - 16)和11名健康志愿者,测定前臂血流量(FBF,静脉阻塞体积描记法)和肱动脉压,以计算前臂血管阻力(FVR)。尽管感染性休克患者的基线FBF增加(6.1(标准差1.5)ml·min⁻¹·(100 ml组织)⁻¹,而志愿者为4.7(1.4)),但外源性一氧化氮(硝普钠)和乙酰胆碱引起的FVR显著降低在两组之间并无差异。然而,与志愿者相比,低剂量的N(G)-甲基-L-精氨酸乙酸盐(L-NMMA)减轻内源性一氧化氮生成,导致感染性休克患者的FVR显著增加(+6.7 mmHg·min·ml⁻¹)。去氧肾上腺素(FVR:+9.9 vs对照组的+30.7 mmHg·min·ml⁻¹)和血管紧张素II(FVR:+9.0 vs +67.4 mmHg·min·ml⁻¹)引起的局部血管收缩明显受损。相比之下,血管加压素在志愿者中未引起血管收缩的剂量,却能使感染性休克患者的FVR显著增加(+10.0 mmHg·min·ml⁻¹)。在感染性休克患者的前臂,α1受体激动剂和血管紧张素II受体激动剂引起的血管收缩选择性受损,而血管加压素引起的血管收缩反应则增强。这些发现排除了感染性休克患者血管运动活性普遍受损的情况,并为血管加压素的应用提供了理论依据。